United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Report 2016

December 2016 | 102 pages | ID: U248C263CA7EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Attention Deficit Hyperactivity Disorder (ADHD) Drug

Revenue, means the sales value of Attention Deficit Hyperactivity Disorder (ADHD) Drug

This report studies sales (consumption) of Attention Deficit Hyperactivity Disorder (ADHD) Drug in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Eli Lilly
• Janssen Pharmaceuticals, Inc.
• Shire
• Perdue Pharma
• Glaxosmith Kline
• Decartis
• Celltech Group
• Johnson & Johnson

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Stimulants (Amphetamines, Methylphenidate)
• Non-Stimulants
• Antidepressants
• Blood Pressure Medicines

Split by applications, this report focuses on sales, market share and growth rate of Attention Deficit Hyperactivity Disorder (ADHD) Drug in each application, can be divided into

• Adults
• Children
• Application 3

Contents

United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Report 2016

1 ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) DRUG OVERVIEW

1.1 Product Overview and Scope of Attention Deficit Hyperactivity Disorder (ADHD) Drug
1.2 Classification of Attention Deficit Hyperactivity Disorder (ADHD) Drug
  1.2.1 Stimulants (Amphetamines, Methylphenidate)
  1.2.2 Non-Stimulants
  1.2.3 Antidepressants
  1.2.4 Blood Pressure Medicines
1.3 Application of Attention Deficit Hyperactivity Disorder (ADHD) Drug
  1.3.1 Adults
  1.3.2 Children
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Attention Deficit Hyperactivity Disorder (ADHD) Drug (2011-2021)
  1.4.1 United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales and Growth Rate (2011-2021)
  1.4.2 United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue and Growth Rate (2011-2021)

2 UNITED STATES ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) DRUG COMPETITION BY MANUFACTURERS

2.1 United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Average Price by Manufactures (2015 and 2016)
2.4 Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Competitive Situation and Trends
  2.4.1 Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Concentration Rate
  2.4.2 Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) DRUG SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales and Market Share by Type (2011-2016)
3.2 United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue and Market Share by Type (2011-2016)
3.3 United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Price by Type (2011-2016)
3.4 United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Growth Rate by Type (2011-2016)

4 UNITED STATES ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) DRUG SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales and Market Share by Application (2011-2016)
4.2 United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) DRUG MANUFACTURERS PROFILES/ANALYSIS

5.1 Eli Lilly
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Attention Deficit Hyperactivity Disorder (ADHD) Drug Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Janssen Pharmaceuticals, Inc.
  5.2.2 Attention Deficit Hyperactivity Disorder (ADHD) Drug Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Janssen Pharmaceuticals, Inc. Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 Shire
  5.3.2 Attention Deficit Hyperactivity Disorder (ADHD) Drug Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 Shire Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Perdue Pharma
  5.4.2 Attention Deficit Hyperactivity Disorder (ADHD) Drug Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Perdue Pharma Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Glaxosmith Kline
  5.5.2 Attention Deficit Hyperactivity Disorder (ADHD) Drug Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Glaxosmith Kline Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Decartis
  5.6.2 Attention Deficit Hyperactivity Disorder (ADHD) Drug Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Decartis Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Celltech Group
  5.7.2 Attention Deficit Hyperactivity Disorder (ADHD) Drug Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Celltech Group Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Johnson & Johnson
  5.8.2 Attention Deficit Hyperactivity Disorder (ADHD) Drug Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview

6 ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) DRUG MANUFACTURING COST ANALYSIS

6.1 Attention Deficit Hyperactivity Disorder (ADHD) Drug Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Attention Deficit Hyperactivity Disorder (ADHD) Drug

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Attention Deficit Hyperactivity Disorder (ADHD) Drug Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Attention Deficit Hyperactivity Disorder (ADHD) Drug Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) DRUG MARKET FORECAST (2016-2021)

10.1 United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales, Revenue Forecast (2016-2021)
10.2 United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Forecast by Type (2016-2021)
10.3 United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Forecast by Application (2016-2021)
10.4 Attention Deficit Hyperactivity Disorder (ADHD) Drug Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Disclosure Section
Research Methodology
Data Source
Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Attention Deficit Hyperactivity Disorder (ADHD) Drug
Table Classification of Attention Deficit Hyperactivity Disorder (ADHD) Drug
Figure United States Sales Market Share of Attention Deficit Hyperactivity Disorder (ADHD) Drug by Type in 2015
Figure Stimulants (Amphetamines, Methylphenidate) Picture
Figure Non-Stimulants Picture
Figure Antidepressants Picture
Figure Blood Pressure Medicines Picture
Table Application of Attention Deficit Hyperactivity Disorder (ADHD) Drug
Figure United States Sales Market Share of Attention Deficit Hyperactivity Disorder (ADHD) Drug by Application in 2015
Figure Adults Examples
Figure Children Examples
Figure United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales and Growth Rate (2011-2021)
Figure United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue and Growth Rate (2011-2021)
Table United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales of Key Manufacturers (2015 and 2016)
Table United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Share by Manufacturers
Figure 2016 Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Share by Manufacturers
Table United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue by Manufacturers (2015 and 2016)
Table United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Share by Manufacturers
Table 2016 United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Share by Manufacturers
Table United States Market Attention Deficit Hyperactivity Disorder (ADHD) Drug Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Attention Deficit Hyperactivity Disorder (ADHD) Drug Average Price of Key Manufacturers in 2015
Figure Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Share of Top 3 Manufacturers
Figure Attention Deficit Hyperactivity Disorder (ADHD) Drug Market Share of Top 5 Manufacturers
Table United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales by Type (2011-2016)
Table United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Share by Type (2011-2016)
Figure United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Type in 2015
Table United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue and Market Share by Type (2011-2016)
Table United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Attention Deficit Hyperactivity Disorder (ADHD) Drug by Type (2011-2016)
Table United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Price by Type (2011-2016)
Figure United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Growth Rate by Type (2011-2016)
Table United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales by Application (2011-2016)
Table United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Application (2011-2016)
Figure United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share by Application in 2015
Table United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Growth Rate by Application (2011-2016)
Figure United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Growth Rate by Application (2011-2016)
Table Eli Lilly Basic Information List
Table Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Eli Lilly Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share (2011-2016)
Table Janssen Pharmaceuticals, Inc. Basic Information List
Table Janssen Pharmaceuticals, Inc. Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Janssen Pharmaceuticals, Inc. Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share (2011-2016)
Table Shire Basic Information List
Table Shire Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Shire Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share (2011-2016)
Table Perdue Pharma Basic Information List
Table Perdue Pharma Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Perdue Pharma Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share (2011-2016)
Table Glaxosmith Kline Basic Information List
Table Glaxosmith Kline Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Glaxosmith Kline Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share (2011-2016)
Table Decartis Basic Information List
Table Decartis Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Decartis Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share (2011-2016)
Table Celltech Group Basic Information List
Table Celltech Group Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Celltech Group Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share (2011-2016)
Table Johnson & Johnson Basic Information List
Table Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales, Revenue, Price and Gross Margin (2011-2016)
Table Johnson & Johnson Attention Deficit Hyperactivity Disorder (ADHD) Drug Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Attention Deficit Hyperactivity Disorder (ADHD) Drug
Figure Manufacturing Process Analysis of Attention Deficit Hyperactivity Disorder (ADHD) Drug
Figure Attention Deficit Hyperactivity Disorder (ADHD) Drug Industrial Chain Analysis
Table Raw Materials Sources of Attention Deficit Hyperactivity Disorder (ADHD) Drug Major Manufacturers in 2015
Table Major Buyers of Attention Deficit Hyperactivity Disorder (ADHD) Drug
Table Distributors/Traders List
Figure United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Production and Growth Rate Forecast (2016-2021)
Figure United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Revenue and Growth Rate Forecast (2016-2021)
Table United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Production Forecast by Type (2016-2021)
Table United States Attention Deficit Hyperactivity Disorder (ADHD) Drug Consumption Forecast by Application (2016-2021)